Skip to content
10-Q

Quarterly Report

Zomedica Corp. ZOMDF

0001558370-25-010512

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 979.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 979.95M sh
Shares Diluted Q2 2025 · Jun 30, 2025 979.95M sh
Shares Diluted Q2 2025 · Jun 30, 2024 979.95M sh
Shares Diluted Q2 2025 · Jun 30, 2024 979.95M sh
Capex Q2 2025 · Jun 30, 2025 $417K
Capex Q2 2025 · Jun 30, 2024 $3.56M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$12.09M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$14.31M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $8.13M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $7.02M
Stockholders Equity Q2 2025 · Jun 30, 2025 $125.36M
Stockholders Equity Q2 2025 · Mar 31, 2025 $132.44M
Stockholders Equity Q2 2025 · Dec 31, 2024 $195.66M
Stockholders Equity Q2 2025 · Jun 30, 2024 $208.72M
Stockholders Equity Q2 2025 · Mar 31, 2024 $231.9M
Stockholders Equity Q2 2025 · Dec 31, 2023 $240.02M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.13M
Current Liabilities Q2 2025 · Dec 31, 2024 $9.33M
Total Liabilities Q2 2025 · Jun 30, 2025 $11.12M
Total Liabilities Q2 2025 · Dec 31, 2024 $11.7M
Current Assets Q2 2025 · Jun 30, 2025 $68.6M
Current Assets Q2 2025 · Dec 31, 2024 $81.77M
Total Assets Q2 2025 · Jun 30, 2025 $136.47M
Total Assets Q2 2025 · Dec 31, 2024 $207.36M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.07
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.02
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.03
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.07
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.02
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.03
Rd Expense Q2 2025 · Jun 30, 2025 $1.89M
Rd Expense Q2 2025 · Jun 30, 2025 $3.74M
Rd Expense Q2 2025 · Jun 30, 2024 $1.51M
Rd Expense Q2 2025 · Jun 30, 2024 $3.28M
Net Income Q2 2025 · Jun 30, 2025 −$7.4M
Net Income Q2 2025 · Jun 30, 2025 −$71.21M
Net Income Q2 2025 · Jun 30, 2024 −$23.93M
Net Income Q2 2025 · Jun 30, 2024 −$33.09M
Operating Income Q2 2025 · Jun 30, 2025 −$8.04M
Operating Income Q2 2025 · Jun 30, 2025 −$72.58M
Operating Income Q2 2025 · Jun 30, 2024 −$25.07M
Operating Income Q2 2025 · Jun 30, 2024 −$35.45M
Gross Profit Q2 2025 · Jun 30, 2025 $4.67M
Gross Profit Q2 2025 · Jun 30, 2025 $9.07M
Gross Profit Q2 2025 · Jun 30, 2024 $4.36M
Gross Profit Q2 2025 · Jun 30, 2024 $8.48M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $2.3M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $4.39M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.77M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $3.91M
Revenue Q2 2025 · Jun 30, 2025 $6.96M
Revenue Q2 2025 · Jun 30, 2025 $13.46M
Revenue Q2 2025 · Jun 30, 2024 $6.13M
Revenue Q2 2025 · Jun 30, 2024 $12.39M